The postbiotics market was valued at $1,579.0 million in 2021, and is estimated to reach $3,025.8 million by 2031, registering a CAGR of 6.8% from 2022 to 2031. In 2021, the powdered postbiotic segment accounted for the majority of the total postbiotic market. Postbiotics are soluble factors that provide physiological benefits to the host and are secreted by live bacteria or released after bacterial lysis. Metabiotics, biogenic, and metabolites are other names for postbiotics, and they are most commonly used as supplements and cosmetics.
The demand for various types of nutraceutical products is rapidly increasing. The primary reason for the increase in demand is growing awareness of the health benefits of using nutraceuticals and nutraceutical supplements. Furthermore, the adoption of hectic lifestyles due to work pressure, combined with increased consumption of fast and unhealthy foods, is driving consumers to seek out supplements that can help them maintain their health and well-being. Fast food consumption is increasing, which is causing diseases such as high cholesterol, obesity, bone degeneration, and heart disease. More and more people are engaging in fitness activities such as visiting gyms and athletic centers to maintain their health, and they are combining these activities with postbiotic nutraceuticals to achieve the best results.
Consumer lifestyle changes have been one of the major factors contributing to the growing popularity of functional foods and beverages in developing economies. Customers' food habits are changing in Asia-Pacific countries as per capita income rises. The rise in aspiration and preference for a luxurious lifestyle has resulted in a significant increase in market size and overall demand. Functional beverages are made up of specific nutrients and supplements, such as probiotics, which improve athletic performance and metabolism. Appropriate nutrition is a necessary prerequisite for effective athletic performance improvement, conditioning, recovery from fatigue after exercise, and rapid injury recovery. It also aids in the management of diabetes. As a result, the demand for functional beverages such as natural sports and energy drinks is rapidly increasing.
The difficulties that manufacturers face during the manufacturing process impede the postbiotic market. Many times, the extraction of the ingredients required to make postbiotics is difficult, and the end result is a very small amount of the ingredient. The ingredient's stability is also important, as many nutraceutical ingredients are highly unstable and decompose quickly in unfavorable conditions. As a result, these ingredients must be carefully stored and handled, which sometimes necessitates large investments in equipment. Furthermore, due to the various textures and forms of the ingredients, manufacturing postbiotics can be difficult at times, making it difficult for the engaged stakeholders to manufacture such types of nutraceuticals.
Postbiotics are becoming increasingly popular as more consumers add nutraceuticals to their regular diets. However, many consumers are looking for supplements that are both convenient and tasty, making such products easier to consume. Newer types of nutraceuticals, such as gummies, jellies, and soft gels, are being introduced to the market, and their popularity is growing. They come in a variety of shapes, sizes, flavors, and concentrations. Most of these nutraceuticals are intended for daily consumption, and thus these varieties allow consumers to consume these nutraceuticals on a daily basis if they are perceived to be enjoyable to consume. Furthermore, these types of nutraceuticals are becoming increasingly popular among children.
The postbiotic market is segmented on the basis of form, application, and region. By form, the postbiotic market is classified into powder, liquid, and others. Depending on the application, the market is categorized into personal care and cosmetics, food and beverage, animal feed, pharmaceuticals, and others. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and LAMEA.
Some of the major players analyzed in this report are Sami-Sabinsa Group Limited, Woresan GmbH, Novachem SRL, ILDONG HOLDINGS CO., LTD., Church & Dwight Co., Inc., Danish Agro, Lamberti S.p.A., Cargill, Incorporated, Adare Pharma Solutions, Lactobio A/S, Archer Daniels Midland Company, Kirin Holdings Company, Limited, Bioflag Group, Probiotics Australia Pty., Ltd., Lesaffre, Otemchi Biotechnologies Pte. Ltd., SILAB, Mitsubishi Corporation, GeneFerm Biotechnology Co., Ltd., and KOREA BeRM co., Ltd.
The demand for various types of nutraceutical products is rapidly increasing. The primary reason for the increase in demand is growing awareness of the health benefits of using nutraceuticals and nutraceutical supplements. Furthermore, the adoption of hectic lifestyles due to work pressure, combined with increased consumption of fast and unhealthy foods, is driving consumers to seek out supplements that can help them maintain their health and well-being. Fast food consumption is increasing, which is causing diseases such as high cholesterol, obesity, bone degeneration, and heart disease. More and more people are engaging in fitness activities such as visiting gyms and athletic centers to maintain their health, and they are combining these activities with postbiotic nutraceuticals to achieve the best results.
Consumer lifestyle changes have been one of the major factors contributing to the growing popularity of functional foods and beverages in developing economies. Customers' food habits are changing in Asia-Pacific countries as per capita income rises. The rise in aspiration and preference for a luxurious lifestyle has resulted in a significant increase in market size and overall demand. Functional beverages are made up of specific nutrients and supplements, such as probiotics, which improve athletic performance and metabolism. Appropriate nutrition is a necessary prerequisite for effective athletic performance improvement, conditioning, recovery from fatigue after exercise, and rapid injury recovery. It also aids in the management of diabetes. As a result, the demand for functional beverages such as natural sports and energy drinks is rapidly increasing.
The difficulties that manufacturers face during the manufacturing process impede the postbiotic market. Many times, the extraction of the ingredients required to make postbiotics is difficult, and the end result is a very small amount of the ingredient. The ingredient's stability is also important, as many nutraceutical ingredients are highly unstable and decompose quickly in unfavorable conditions. As a result, these ingredients must be carefully stored and handled, which sometimes necessitates large investments in equipment. Furthermore, due to the various textures and forms of the ingredients, manufacturing postbiotics can be difficult at times, making it difficult for the engaged stakeholders to manufacture such types of nutraceuticals.
Postbiotics are becoming increasingly popular as more consumers add nutraceuticals to their regular diets. However, many consumers are looking for supplements that are both convenient and tasty, making such products easier to consume. Newer types of nutraceuticals, such as gummies, jellies, and soft gels, are being introduced to the market, and their popularity is growing. They come in a variety of shapes, sizes, flavors, and concentrations. Most of these nutraceuticals are intended for daily consumption, and thus these varieties allow consumers to consume these nutraceuticals on a daily basis if they are perceived to be enjoyable to consume. Furthermore, these types of nutraceuticals are becoming increasingly popular among children.
The postbiotic market is segmented on the basis of form, application, and region. By form, the postbiotic market is classified into powder, liquid, and others. Depending on the application, the market is categorized into personal care and cosmetics, food and beverage, animal feed, pharmaceuticals, and others. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and LAMEA.
Some of the major players analyzed in this report are Sami-Sabinsa Group Limited, Woresan GmbH, Novachem SRL, ILDONG HOLDINGS CO., LTD., Church & Dwight Co., Inc., Danish Agro, Lamberti S.p.A., Cargill, Incorporated, Adare Pharma Solutions, Lactobio A/S, Archer Daniels Midland Company, Kirin Holdings Company, Limited, Bioflag Group, Probiotics Australia Pty., Ltd., Lesaffre, Otemchi Biotechnologies Pte. Ltd., SILAB, Mitsubishi Corporation, GeneFerm Biotechnology Co., Ltd., and KOREA BeRM co., Ltd.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the postbiotic market analysis from 2021 to 2031 to identify the prevailing postbiotic market opportunities.
- Market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights buyers' and suppliers' potency to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
- An in-depth analysis of the postbiotic market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global postbiotic market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Form
- Powder
- Liquid
- Others
By Application
- Personal Care and Cosmetics
- Food and Beverage
- Animal Feed
- Pharmaceuticals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
Key Market Players
- Adare Pharma Solutions
- Church & Dwight Co., Inc.
- Danish Agro
- woresan GmbH
- ILDONG HOLDINGS CO., LTD.
- Sami-Sabinsa Group Limited
- Lesaffre
- Bioflag Group
- Archer Daniels Midland Company
- Otemchi Biotechnologies Pte. Ltd.
- GeneFerm Biotechnology Co., Ltd.
- Mitsubishi Corporation
- Probiotics Australia Pty., Ltd.
- Cargill, Incorporated
- Lactobio A/S
- SILAB
- KOREA BeRM co., Ltd
- Novachem SRL
- Kirin Holdings Company, Limited
- Lamberti S.p.A.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: POSTBIOTIC MARKET, BY FORM
4.1 Overview
4.1.1 Market size and forecast
4.2 Powder
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Liquid
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4 Others
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
CHAPTER 5: POSTBIOTIC MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Personal Care and Cosmetics
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Food and Beverage
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Animal Feed
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5 Pharmaceuticals
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
5.6 Others
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market share analysis by country
CHAPTER 6: POSTBIOTIC MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Form
6.2.3 North America Market size and forecast, by Application
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Key market trends, growth factors and opportunities
6.2.4.1.2 Market size and forecast, by Form
6.2.4.1.3 Market size and forecast, by Application
6.2.4.2 Canada
6.2.4.2.1 Key market trends, growth factors and opportunities
6.2.4.2.2 Market size and forecast, by Form
6.2.4.2.3 Market size and forecast, by Application
6.2.4.3 Mexico
6.2.4.3.1 Key market trends, growth factors and opportunities
6.2.4.3.2 Market size and forecast, by Form
6.2.4.3.3 Market size and forecast, by Application
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Form
6.3.3 Europe Market size and forecast, by Application
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Key market trends, growth factors and opportunities
6.3.4.1.2 Market size and forecast, by Form
6.3.4.1.3 Market size and forecast, by Application
6.3.4.2 France
6.3.4.2.1 Key market trends, growth factors and opportunities
6.3.4.2.2 Market size and forecast, by Form
6.3.4.2.3 Market size and forecast, by Application
6.3.4.3 UK
6.3.4.3.1 Key market trends, growth factors and opportunities
6.3.4.3.2 Market size and forecast, by Form
6.3.4.3.3 Market size and forecast, by Application
6.3.4.4 Italy
6.3.4.4.1 Key market trends, growth factors and opportunities
6.3.4.4.2 Market size and forecast, by Form
6.3.4.4.3 Market size and forecast, by Application
6.3.4.5 Spain
6.3.4.5.1 Key market trends, growth factors and opportunities
6.3.4.5.2 Market size and forecast, by Form
6.3.4.5.3 Market size and forecast, by Application
6.3.4.6 Netherlands
6.3.4.6.1 Key market trends, growth factors and opportunities
6.3.4.6.2 Market size and forecast, by Form
6.3.4.6.3 Market size and forecast, by Application
6.3.4.7 Rest of Europe
6.3.4.7.1 Key market trends, growth factors and opportunities
6.3.4.7.2 Market size and forecast, by Form
6.3.4.7.3 Market size and forecast, by Application
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Form
6.4.3 Asia-Pacific Market size and forecast, by Application
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Key market trends, growth factors and opportunities
6.4.4.1.2 Market size and forecast, by Form
6.4.4.1.3 Market size and forecast, by Application
6.4.4.2 Japan
6.4.4.2.1 Key market trends, growth factors and opportunities
6.4.4.2.2 Market size and forecast, by Form
6.4.4.2.3 Market size and forecast, by Application
6.4.4.3 India
6.4.4.3.1 Key market trends, growth factors and opportunities
6.4.4.3.2 Market size and forecast, by Form
6.4.4.3.3 Market size and forecast, by Application
6.4.4.4 South Korea
6.4.4.4.1 Key market trends, growth factors and opportunities
6.4.4.4.2 Market size and forecast, by Form
6.4.4.4.3 Market size and forecast, by Application
6.4.4.5 Australia
6.4.4.5.1 Key market trends, growth factors and opportunities
6.4.4.5.2 Market size and forecast, by Form
6.4.4.5.3 Market size and forecast, by Application
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Key market trends, growth factors and opportunities
6.4.4.6.2 Market size and forecast, by Form
6.4.4.6.3 Market size and forecast, by Application
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Form
6.5.3 LAMEA Market size and forecast, by Application
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Key market trends, growth factors and opportunities
6.5.4.1.2 Market size and forecast, by Form
6.5.4.1.3 Market size and forecast, by Application
6.5.4.2 Middle East
6.5.4.2.1 Key market trends, growth factors and opportunities
6.5.4.2.2 Market size and forecast, by Form
6.5.4.2.3 Market size and forecast, by Application
6.5.4.3 Africa
6.5.4.3.1 Key market trends, growth factors and opportunities
6.5.4.3.2 Market size and forecast, by Form
6.5.4.3.3 Market size and forecast, by Application
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Sami-Sabinsa Group Limited
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 woresan GmbH
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Novachem SRL
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 ILDONG HOLDINGS CO.,LTD.
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Church & Dwight Co., Inc
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Danish Agro
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Lamberti S.p.A.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Cargill, Incorporated
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Adare Pharma Solutions
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Lactobio A/S
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
8.11 Archer Daniels Midland Company
8.11.1 Company overview
8.11.2 Company snapshot
8.11.3 Operating business segments
8.11.4 Product portfolio
8.11.5 Business performance
8.11.6 Key strategic moves and developments
8.12 Kirin Holdings Company, Limited.
8.12.1 Company overview
8.12.2 Company snapshot
8.12.3 Operating business segments
8.12.4 Product portfolio
8.12.5 Business performance
8.12.6 Key strategic moves and developments
8.13 Bioflag Group
8.13.1 Company overview
8.13.2 Company snapshot
8.13.3 Operating business segments
8.13.4 Product portfolio
8.13.5 Business performance
8.13.6 Key strategic moves and developments
8.14 Probiotics Australia Pty., Ltd.
8.14.1 Company overview
8.14.2 Company snapshot
8.14.3 Operating business segments
8.14.4 Product portfolio
8.14.5 Business performance
8.14.6 Key strategic moves and developments
8.15 Lesaffre
8.15.1 Company overview
8.15.2 Company snapshot
8.15.3 Operating business segments
8.15.4 Product portfolio
8.15.5 Business performance
8.15.6 Key strategic moves and developments
8.16 Otemchi Biotechnologies Pte. Ltd.,
8.16.1 Company overview
8.16.2 Company snapshot
8.16.3 Operating business segments
8.16.4 Product portfolio
8.16.5 Business performance
8.16.6 Key strategic moves and developments
8.17 SILAB
8.17.1 Company overview
8.17.2 Company snapshot
8.17.3 Operating business segments
8.17.4 Product portfolio
8.17.5 Business performance
8.17.6 Key strategic moves and developments
8.18 Mitsubishi Corporation
8.18.1 Company overview
8.18.2 Company snapshot
8.18.3 Operating business segments
8.18.4 Product portfolio
8.18.5 Business performance
8.18.6 Key strategic moves and developments
8.19 GeneFerm Biotechnology Co., Ltd.
8.19.1 Company overview
8.19.2 Company snapshot
8.19.3 Operating business segments
8.19.4 Product portfolio
8.19.5 Business performance
8.19.6 Key strategic moves and developments
8.20 KOREA BeRM co.,Ltd
8.20.1 Company overview
8.20.2 Company snapshot
8.20.3 Operating business segments
8.20.4 Product portfolio
8.20.5 Business performance
8.20.6 Key strategic moves and developments
List of Tables
Table 1. Global Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 2. Postbiotic Market, for Powder, by Region, 2021-2031 (Revenue, $Million)
Table 3. Postbiotic Market, for Powder, by Country, 2021-2031 (Revenue, $Million)
Table 4. Postbiotic Market, for Liquid, by Region, 2021-2031 (Revenue, $Million)
Table 5. Postbiotic Market, for Liquid, by Country, 2021-2031 (Revenue, $Million)
Table 6. Postbiotic Market, for Others, by Region, 2021-2031 (Revenue, $Million)
Table 7. Postbiotic Market, for Others, by Country, 2021-2031 (Revenue, $Million)
Table 8. Global Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 9. Postbiotic Market, for Personal Care and Cosmetics, by Region, 2021-2031 (Revenue, $Million)
Table 10. Postbiotic Market, for Personal Care and Cosmetics, by Country, 2021-2031 (Revenue, $Million)
Table 11. Postbiotic Market, for Food and Beverage, by Region, 2021-2031 (Revenue, $Million)
Table 12. Postbiotic Market, for Food and Beverage, by Country, 2021-2031 (Revenue, $Million)
Table 13. Postbiotic Market, for Animal Feed, by Region, 2021-2031 (Revenue, $Million)
Table 14. Postbiotic Market, for Animal Feed, by Country, 2021-2031 (Revenue, $Million)
Table 15. Postbiotic Market, for Pharmaceuticals, by Region, 2021-2031 (Revenue, $Million)
Table 16. Postbiotic Market, for Pharmaceuticals, by Country, 2021-2031 (Revenue, $Million)
Table 17. Postbiotic Market, for Others, by Region, 2021-2031 (Revenue, $Million)
Table 18. Postbiotic Market, for Others, by Country, 2021-2031 (Revenue, $Million)
Table 19. Postbiotic Market, by Region, 2021-2031 (Revenue, $Million)
Table 20. North America Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 21. North America Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 22. North America Postbiotic Market, by Country, 2021-2031 (Revenue, $Million)
Table 23. U.S. Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 24. U.S. Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 25. Canada Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 26. Canada Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 27. Mexico Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 28. Mexico Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 29. Europe Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 30. Europe Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 31. Europe Postbiotic Market, by Country, 2021-2031 (Revenue, $Million)
Table 32. Germany Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 33. Germany Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 34. France Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 35. France Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 36. UK Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 37. UK Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 38. Italy Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 39. Italy Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 40. Spain Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 41. Spain Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 42. Netherlands Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 43. Netherlands Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 44. Rest of Europe Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 45. Rest of Europe Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 46. Asia-Pacific Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 47. Asia-Pacific Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 48. Asia-Pacific Postbiotic Market, by Country, 2021-2031 (Revenue, $Million)
Table 49. China Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 50. China Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 51. Japan Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 52. Japan Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 53. India Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 54. India Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 55. South Korea Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 56. South Korea Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 57. Australia Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 58. Australia Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 59. Rest of Asia-Pacific Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 60. Rest of Asia-Pacific Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 61. LAMEA Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 62. LAMEA Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 63. LAMEA Postbiotic Market, by Country, 2021-2031 (Revenue, $Million)
Table 64. Latin America Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 65. Latin America Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 66. Middle East Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 67. Middle East Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 68. Africa Postbiotic Market, by Form, 2021-2031 (Revenue, $Million)
Table 69. Africa Postbiotic Market, by Application, 2021-2031 (Revenue, $Million)
Table 70. Sami-Sabinsa Group Limited: Company Snapshot
Table 71. Sami-Sabinsa Group Limited: Operating Segments
Table 72. Sami-Sabinsa Group Limited: Product Portfolio
Table 73. Sami-Sabinsa Group Limited: Net Sales,
Table 74. Sami-Sabinsa Group Limited: Key Stratergies
Table 75. Woresan Gmbh: Company Snapshot
Table 76. Woresan Gmbh: Operating Segments
Table 77. Woresan Gmbh: Product Portfolio
Table 78. Woresan Gmbh: Net Sales,
Table 79. Woresan Gmbh: Key Stratergies
Table 80. Novachem Srl: Company Snapshot
Table 81. Novachem Srl: Operating Segments
Table 82. Novachem Srl: Product Portfolio
Table 83. Novachem Srl: Net Sales,
Table 84. Novachem Srl: Key Stratergies
Table 85. Ildong Holdings Co.Ltd.: Company Snapshot
Table 86. Ildong Holdings Co.Ltd.: Operating Segments
Table 87. Ildong Holdings Co.Ltd.: Product Portfolio
Table 88. Ildong Holdings Co.Ltd.: Net Sales,
Table 89. Ildong Holdings Co.Ltd.: Key Stratergies
Table 90. Church & Dwight Co. Inc: Company Snapshot
Table 91. Church & Dwight Co. Inc: Operating Segments
Table 92. Church & Dwight Co. Inc: Product Portfolio
Table 93. Church & Dwight Co. Inc: Net Sales,
Table 94. Church & Dwight Co. Inc: Key Stratergies
Table 95. Danish Agro: Company Snapshot
Table 96. Danish Agro: Operating Segments
Table 97. Danish Agro: Product Portfolio
Table 98. Danish Agro: Net Sales,
Table 99. Danish Agro: Key Stratergies
Table 100. Lamberti S.P.A.: Company Snapshot
Table 101. Lamberti S.P.A.: Operating Segments
Table 102. Lamberti S.P.A.: Product Portfolio
Table 103. Lamberti S.P.A.: Net Sales,
Table 104. Lamberti S.P.A.: Key Stratergies
Table 105. Cargill, Incorporated: Company Snapshot
Table 106. Cargill, Incorporated: Operating Segments
Table 107. Cargill, Incorporated: Product Portfolio
Table 108. Cargill, Incorporated: Net Sales,
Table 109. Cargill, Incorporated: Key Stratergies
Table 110. Adare Pharma Solutions: Company Snapshot
Table 111. Adare Pharma Solutions: Operating Segments
Table 112. Adare Pharma Solutions: Product Portfolio
Table 113. Adare Pharma Solutions: Net Sales,
Table 114. Adare Pharma Solutions: Key Stratergies
Table 115. Lactobio A/S: Company Snapshot
Table 116. Lactobio A/S: Operating Segments
Table 117. Lactobio A/S: Product Portfolio
Table 118. Lactobio A/S: Net Sales,
Table 119. Lactobio A/S: Key Stratergies
Table 120. Archer Daniels Midland Company: Company Snapshot
Table 121. Archer Daniels Midland Company: Operating Segments
Table 122. Archer Daniels Midland Company: Product Portfolio
Table 123. Archer Daniels Midland Company: Net Sales,
Table 124. Archer Daniels Midland Company: Key Stratergies
Table 125. Kirin Holdings Company, Limited.: Company Snapshot
Table 126. Kirin Holdings Company, Limited.: Operating Segments
Table 127. Kirin Holdings Company, Limited.: Product Portfolio
Table 128. Kirin Holdings Company, Limited.: Net Sales,
Table 129. Kirin Holdings Company, Limited.: Key Stratergies
Table 130. Bioflag Group: Company Snapshot
Table 131. Bioflag Group: Operating Segments
Table 132. Bioflag Group: Product Portfolio
Table 133. Bioflag Group: Net Sales,
Table 134. Bioflag Group: Key Stratergies
Table 135. Probiotics Australia Pty. Ltd.: Company Snapshot
Table 136. Probiotics Australia Pty. Ltd.: Operating Segments
Table 137. Probiotics Australia Pty. Ltd.: Product Portfolio
Table 138. Probiotics Australia Pty. Ltd.: Net Sales,
Table 139. Probiotics Australia Pty. Ltd.: Key Stratergies
Table 140. Lesaffre: Company Snapshot
Table 141. Lesaffre: Operating Segments
Table 142. Lesaffre: Product Portfolio
Table 143. Lesaffre: Net Sales,
Table 144. Lesaffre: Key Stratergies
Table 145. Otemchi Biotechnologies Pte. Ltd.: Company Snapshot
Table 146. Otemchi Biotechnologies Pte. Ltd.: Operating Segments
Table 147. Otemchi Biotechnologies Pte. Ltd.: Product Portfolio
Table 148. Otemchi Biotechnologies Pte. Ltd.: Net Sales,
Table 149. Otemchi Biotechnologies Pte. Ltd.: Key Stratergies
Table 150. Silab: Company Snapshot
Table 151. Silab: Operating Segments
Table 152. Silab: Product Portfolio
Table 153. Silab: Net Sales,
Table 154. Silab: Key Stratergies
Table 155. Mitsubishi Corporation: Company Snapshot
Table 156. Mitsubishi Corporation: Operating Segments
Table 157. Mitsubishi Corporation: Product Portfolio
Table 158. Mitsubishi Corporation: Net Sales,
Table 159. Mitsubishi Corporation: Key Stratergies
Table 160. Geneferm Biotechnology Co. Ltd.: Company Snapshot
Table 161. Geneferm Biotechnology Co. Ltd.: Operating Segments
Table 162. Geneferm Biotechnology Co. Ltd.: Product Portfolio
Table 163. Geneferm Biotechnology Co. Ltd.: Net Sales,
Table 164. Geneferm Biotechnology Co. Ltd.: Key Stratergies
Table 165. Korea Berm Co.Ltd: Company Snapshot
Table 166. Korea Berm Co.Ltd: Operating Segments
Table 167. Korea Berm Co.Ltd: Product Portfolio
Table 168. Korea Berm Co.Ltd: Net Sales,
Table 169. Korea Berm Co.Ltd: Key Stratergies
List of Figures
Figure 1. Postbiotic Market Segmentation
Figure 2. Postbiotic Market, 2021-2031
Figure 3. Postbiotic Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Postbiotic Market: Drivers, Restraints and Opportunities
Figure 12. Postbiotic Market, by Form, 2021 (%)
Figure 13. Comparative Share Analysis of Powder Postbiotic Market, 2021-2031 (%)
Figure 14. Comparative Share Analysis of Liquid Postbiotic Market, 2021-2031 (%)
Figure 15. Comparative Share Analysis of Others Postbiotic Market, 2021-2031 (%)
Figure 16. Postbiotic Market, by Application, 2021 (%)
Figure 17. Comparative Share Analysis of Personal Care and Cosmetics Postbiotic Market, 2021-2031 (%)
Figure 18. Comparative Share Analysis of Food and Beverage Postbiotic Market, 2021-2031 (%)
Figure 19. Comparative Share Analysis of Animal Feed Postbiotic Market, 2021-2031 (%)
Figure 20. Comparative Share Analysis of Pharmaceuticals Postbiotic Market, 2021-2031 (%)
Figure 21. Comparative Share Analysis of Others Postbiotic Market, 2021-2031 (%)
Figure 22. Postbiotic Market by Region, 2021
Figure 23. U.S. Postbiotic Market, 2021-2031 ($Million)
Figure 24. Canada Postbiotic Market, 2021-2031 ($Million)
Figure 25. Mexico Postbiotic Market, 2021-2031 ($Million)
Figure 26. Germany Postbiotic Market, 2021-2031 ($Million)
Figure 27. France Postbiotic Market, 2021-2031 ($Million)
Figure 28. Uk Postbiotic Market, 2021-2031 ($Million)
Figure 29. Italy Postbiotic Market, 2021-2031 ($Million)
Figure 30. Spain Postbiotic Market, 2021-2031 ($Million)
Figure 31. Netherlands Postbiotic Market, 2021-2031 ($Million)
Figure 32. Rest of Europe Postbiotic Market, 2021-2031 ($Million)
Figure 33. China Postbiotic Market, 2021-2031 ($Million)
Figure 34. Japan Postbiotic Market, 2021-2031 ($Million)
Figure 35. India Postbiotic Market, 2021-2031 ($Million)
Figure 36. South Korea Postbiotic Market, 2021-2031 ($Million)
Figure 37. Australia Postbiotic Market, 2021-2031 ($Million)
Figure 38. Rest of Asia-Pacific Postbiotic Market, 2021-2031 ($Million)
Figure 39. Latin America Postbiotic Market, 2021-2031 ($Million)
Figure 40. Middle East Postbiotic Market, 2021-2031 ($Million)
Figure 41. Africa Postbiotic Market, 2021-2031 ($Million)
Figure 42. Top Winning Strategies, by Year
Figure 43. Top Winning Strategies, by Development
Figure 44. Top Winning Strategies, by Company
Figure 45. Product Mapping of Top 10 Players
Figure 46. Competitive Dashboard
Figure 47. Competitive Heatmap of Top 10 Key Players
Figure 48. Sami-Sabinsa Group Limited.: Net Sales ($Million)
Figure 49. Woresan Gmbh.: Net Sales ($Million)
Figure 50. Novachem Srl.: Net Sales ($Million)
Figure 51. Ildong Holdings Co.Ltd..: Net Sales ($Million)
Figure 52. Church & Dwight Co. Inc.: Net Sales ($Million)
Figure 53. Danish Agro.: Net Sales ($Million)
Figure 54. Lamberti S.P.A..: Net Sales ($Million)
Figure 55. Cargill, Incorporated.: Net Sales ($Million)
Figure 56. Adare Pharma Solutions.: Net Sales ($Million)
Figure 57. Lactobio A/S.: Net Sales ($Million)
Figure 58. Archer Daniels Midland Company.: Net Sales ($Million)
Figure 59. Kirin Holdings Company, Limited..: Net Sales ($Million)
Figure 60. Bioflag Group.: Net Sales ($Million)
Figure 61. Probiotics Australia Pty. Ltd..: Net Sales ($Million)
Figure 62. Lesaffre.: Net Sales ($Million)
Figure 63. Otemchi Biotechnologies Pte. Ltd..: Net Sales ($Million)
Figure 64. Silab.: Net Sales ($Million)
Figure 65. Mitsubishi Corporation.: Net Sales ($Million)
Figure 66. Geneferm Biotechnology Co. Ltd..: Net Sales ($Million)
Figure 67. Korea Berm Co.Ltd.: Net Sales ($Million)
Executive Summary
According to the report titled, “Postbiotic Market," The postbiotic market was valued at $1.6 billion in 2021, and is estimated to reach $3 billion by 2031, growing at a CAGR of 6.8% from 2022 to 2031.A postbiotic is a preparation of inanimate microorganisms and/or their components that benefits the host's health. Postbiotics are microbial cells that have been deliberately inactivated, with or without metabolites or cell components that contribute to demonstrated health benefits. Postbiotics may help improve the consumer’s immune system, prevent or treat diarrhea, alleviate symptoms of irritable bowel disease, and even lessen the severity of certain allergies.
Key factors driving the growth of the postbiotic market include a rise in the consumption of nutraceutical supplements, increased awareness regarding health and wellbeing, and increasing availability of nutraceutical ingredients across the world. Postbiotics for the skin can help reduce skin damage caused by free radicals, sun exposure, and pollution. It can help reduce the signs of aging skin and keep the skin looking young and fresh for long. Postbiotics also reduce skin inflammation by dampening the skin's inflammatory responses. In addition to preventing damage, postbiotics aid in skin repair and collagen production, resulting in more youthful-looking skin. Because postbiotics have numerous skin benefits, they are commonly used in the production of cosmetics and personal care products such as creams and lotions to protect the skin from the harmful effects of the sun and to aid in skin repair.
The market also offers growth opportunities to the key players in the market. With the world's population growing, the global demand for animal feed is expected to rise due to an increase in meat consumption. According to the Food and Agriculture Organization (FAO), meat production is expected to increase by nearly 70%, aquaculture by 90%, and dairy by 55% by the end of 2050 compared to 2010. The addition of natural fruit and plant material, as well as extracts containing bioactive components to livestock and poultry feed has yielded promising results. These additives have the potential to boost feed efficiency, nutrient digestion, immunological indices, poultry health, and growth performance. Postbiotics have a wide range of pharmacological properties, including but not limited to gut bacteria regulation, digestion improvement, and immunity boosting, all of which contribute to the health of the livestock.
The postbiotic market is segmented on the basis of form, application, and region. By form, the postbiotic market is classified into powder, liquid, and others. Depending on the application, the market is categorized into personal care and cosmetics, food and beverage, animal feed, pharmaceuticals, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Netherlands, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).
The key players profiled in the study include Sami-Sabinsa Group Limited, Woresan GmbH, Novachem SRL, ILDONG HOLDINGS CO., LTD., Church & Dwight Co., Inc., Danish Agro, Lamberti S.p.A., Cargill, Incorporated, Adare Pharma Solutions, Lactobio A/S, Archer Daniels Midland Company, Kirin Holdings Company, Limited, Bioflag Group, Probiotics Australia Pty., Ltd., Lesaffre, Otemchi Biotechnologies Pte. Ltd., SILAB, Mitsubishi Corporation, GeneFerm Biotechnology Co., Ltd., and KOREA BeRM co., Ltd. The players in the market have been actively engaged in the adoption of various strategies such as agreement, product launch, partnership, and expansion to remain competitive and gain advantage over the competitors in the market. For instance, in September 2020, Kirin Holdings Company, Limited launched its IMMUSE brand of nutraceutical products, which include postbiotics to increase their presence in the market.
Key Market Insights
The powdered segment dominated the market in 2021, while the liquid segment is expected to grow the most during the forecast period.Use of postbiotics for personal care and cosmetic products is the highest in 2021 and food and beverage is expected to be the fastest growing application segment during the forecast period.
Europe had the largest market share in 2021, while Asia-Pacific is expected to grow the most during the forecast period.
Companies Mentioned
- Adare Pharma Solutions
- Church & Dwight Co., Inc.
- Danish Agro
- woresan GmbH
- ILDONG HOLDINGS CO., LTD.
- Sami-Sabinsa Group Limited
- Lesaffre
- Bioflag Group
- Archer Daniels Midland Company
- Otemchi Biotechnologies Pte. Ltd.
- GeneFerm Biotechnology Co., Ltd.
- Mitsubishi Corporation
- Probiotics Australia Pty., Ltd.
- Cargill, Incorporated
- Lactobio A/S
- SILAB
- KOREA BeRM co., Ltd
- Novachem SRL
- Kirin Holdings Company, Limited
- Lamberti S.p.A.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 189 |
| Published | December 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 1579 million |
| Forecasted Market Value ( USD | $ 3025.8 million |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
